Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN58369615
ISRCTN58369615
Completed
Not Applicable

Biological factors of insulin resistance and cardiovascular risk factors in women with polycystic ovarian syndrome: modification with diet, metformin, pioglitazone and orlistat

Hull and East Yorkshire Hospitals NHS Trust (UK)0 sites40 target enrollmentFebruary 28, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPolycystic ovarian syndromeNutritional, Metabolic, EndocrinePolycystic Ovarian Syndrome

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Polycystic ovarian syndrome
Sponsor
Hull and East Yorkshire Hospitals NHS Trust (UK)
Enrollment
40
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 28, 2007
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Hull and East Yorkshire Hospitals NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • •The diagnosis of PCOS will be based on evidence of hyperandrogenemia (Free androgen index \> 8, with a history of oligomenorrhea and hirsutism or acne. Non classical 21\-hydroxylase deficiency, hyperprolactinemia, and androgen secreting tumors will be excluded by appropriate tests before the diagnosis of PCOS will be made. Transvaginal ultrasound will also be performed to confirm the diagnosis of PCOS

Exclusion Criteria

  • •1\. No subjects will be taking any medication currently or for the preceding six months
  • •2\. No concurrent illness
  • •3\. Patients not wishing to allow disclosure to their GPs

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Effects of glucocorticoids on human gut bacteria
EUCTR2016-001850-16-DKniversity of Copenhagen, The Novo Nordisk Foundation Center For Basic Metabolic Research, Section of Metabolic Genetic
Completed
Not Applicable
Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow upDiabetes MellitusHypertensionIschemic Heart DiseaseStroke
NCT01412554Oslo University Hospital103
Completed
Not Applicable
Biological variation of insulin resistance, testosterone and cardiovascular risk factors in women with polycystic ovary syndrome: modification with rimonabant compared to metformi
ISRCTN75758249Hull and East Yorkshire Hospitals NHS Trust (UK)20
Completed
Not Applicable
Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1Hypoglycaemia
NCT01347801Rigshospitalet, Denmark40
Recruiting
Not Applicable
Mechanism of ovarian dysfunction in patients with polycystic ovary syndrome and obesity
KCT0006204Gachon University Gil Medical Center115